Quigley v. UNUM Life Insurance Co. of America

340 F. Supp. 2d 215, 2004 U.S. Dist. LEXIS 21114, 2004 WL 2376478
CourtDistrict Court, D. Connecticut
DecidedOctober 12, 2004
Docket3:02CV1083(DJS)
StatusPublished
Cited by2 cases

This text of 340 F. Supp. 2d 215 (Quigley v. UNUM Life Insurance Co. of America) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Quigley v. UNUM Life Insurance Co. of America, 340 F. Supp. 2d 215, 2004 U.S. Dist. LEXIS 21114, 2004 WL 2376478 (D. Conn. 2004).

Opinion

MEMORANDUM OF DECISION

SQUATRITO, District Judge.

Plaintiff Sharon Quigley brings this action pursuant to Section 502 of the Employee Retirement Income Security Act (“ERISA”), 29 U.S.C. § 1132, to recover disability benefits allegedly payable to her as a beneficiary of a group long-term disability policy (“the plan”) administered by defendant UNUM Life Insurance Company of America (“UNUM”). The parties have filed cross-motions for summary judgment. For the reasons set forth herein, plaintiffs motion for summary judgment (dkt.# 31) is GRANTED, and defen *217 dant’s motion for summary judgment (dkt.# 27) is DENIED.

I. FACTS

Quigley claims to suffer from fibromyal-gia. The Mayo Clinic offers the following description of this condition:

You hurt all over and you frequently feel exhausted. Even after numerous tests, your doctor can’t seem to find anything specifically wrong with you. If this sounds familiar, you may have fibro-myalgia, a condition that affects an estimated 3 million to 8 million people in the United States. Approximately 80 percent to 90 percent of affected people are women.
Fibromyalgia is a chronic condition characterized by fatigue and widespread pain in your muscles, ligaments and tendons. Previously, the condition was known by other names such as fibrositis, chronic muscle pain syndrome, psychogenic rheumatism and tension myalgias.
In 1990, the American College of Rheu-matology (ACR) identified specific criteria for fibromyalgia. 1 The ACR classifies a patient with fibromyalgia if at least 11 of 18 specific areas of your body are painful under pressure. Also, you must have had widespread pain lasting at least 3 months.
Although the intensity of your symptoms may vary, they’ll probably never disappear completely. It may be reassuring to know, however, that fibro-myalgia isn’t progressive, crippling or life-threatening.

Mayo Clinic Staff, Fibromyalgia, at http://tvmv.mayoclinic.com/ (dated Apr. 24, 2003) (visited Sept. 23, 2004). With respect to diagnosis, the Mayo Clinic offers the following observations:

Diagnosing fibromyalgia is difficult because there isn’t a single, specific diagnostic laboratory test. In fact, before receiving a diagnosis of fibromyalgia, you may go through several medical tests, such as blood tests and X-rays, only to have the results come back normal. Although these tests may rule out other conditions, such as rheumatoid arthritis, lupus and multiple sclerosis, they can’t confirm fibromyalgia.
The American College of Rheumatology has established some general classification guidelines for fibromyalgia, to help in the assessment and study of the condition. These guidelines require that you have widespread aching for at least 3 months and have a minimum of 11 locations on your body that are abnormally tender under relatively mild pressure. In addition to taking your medical history, a doctor checking for fibromyal-gia will press firmly on specific points on your head, upper body and certain joints so that you can confirm which cause pain.
However, not all doctors agree with the guidelines. Some believe that the criteria are too rigid and that you can have fibromyalgia even if you don’t meet the required number of tender points. Others question how reliable and valid tender points are as a diagnostic tool.

Id. Symptoms include widespread pain, which “generally persists for months at a time and is often accompanied by stiffness;” fatigue and sleep disturbances; irritable bowel syndrome; chronic headaches and facial pain; heightened sensitivity; depression; numbness or tingling sensations in the hands and feet (paresthesia); diffi *218 culty concentrating and mood changes; chest pain or pelvic pain; irritable bladder; dry eyes, skin and mouth; painful menstrual periods; dizziness; and sensation of swollen hands and feet. See id.

The medical records submitted to UNUM and incorporated into its claims file 2 indicate that the process of diagnosing and treating Quigley’s condition began in late 1999. During a visit to her primary care physician, Satesh Singh, M.D., Dr. Singh noted that Quigley complained of “aches and pains in all joints,” and that it was possible that she suffered from arthritis. (Dkt. # 30, at UACL 289). Dr. Singh apparently ordered and reviewed the results of subsequent laboratory tests designed to diagnose arthritis, which he concluded were “not consistent with a generalized arthritis.... ” (Dkt. # 30, at UACL 294). Dr. Singh stated that, “if the aches and pains continue!,] we will arrange a rheumatology 3 opinion.” (Id.).

Quigley’s first rheumatology consultation was with Lewis Parker, M.D., on December 16, 1999. Dr. Parker writes that Quigley

describes the pain as being all over and starting in either the arms or the legs and spreading or becoming more diffuse; the problem is aggravated by standing or walking, typing or repetitive hand use. The pain is most prominent in the morning in association with significant stiffness that may persist until mid-day without any distinct gelling with mobility-

(Id., at UACL 206). Dr. Parker also noted that Quigley experienced dry eyes, mouth, and skin, and that she had suffered occasional paresthesias in her hands and feet. (Id., at UACL 207). Dr. Parker treated Quigley with Naprosyn, Prednisone, Dar-vocet, Sinequan, Ultram, and an injection of Depo-Medrol with mixed results through late 1999 and early 2000. Despite these treatments, Quigley still complained of pain and Dr. Parker noted tenderness in her limbs and back. Dr. Parker listed Quigley’s “problem[s]” as “Syorgen’s syndrome 4 , probable,” “Soft tissue syndrome with bursitis, tendinitis and trigger points,” and “Carpal tunnel syndrome.” (Id., at UACL 200).

On March 13, 2000, Quigley consulted with a second rheumatologist named Ann Parke, M.D. for the first time. Both Dr. Parke and Miriam Borden, M.D., a fellow who examined Quigley with Dr. Parke, noted that Dr. Parker had referred Quig-ley to Dr. Parke because he suspected that Quigley may have Sjorgen’s syndrome. In March of 2000, Dr. Parke noted Quigley’s “complaints consisting of joint aches and pains, fatigue, one to two hours or early morning stiffness, and recently dry eyes and dry mouth.” (Id., at UACL 338). Dr. Parke also noted Quigley’s “characteristic *219 Cushingoid features,” 5 and ordered an endocrinology consultation. (Id.). Following Quigley’s initial consultation, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Beauclair v. Barnhart
453 F. Supp. 2d 1259 (D. Kansas, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
340 F. Supp. 2d 215, 2004 U.S. Dist. LEXIS 21114, 2004 WL 2376478, Counsel Stack Legal Research, https://law.counselstack.com/opinion/quigley-v-unum-life-insurance-co-of-america-ctd-2004.